脑静脉血栓形成患者的血栓栓塞事件、出血与死亡率:一项全国性队列研究
基于丹麦登记数据,纳入1996—2018年首次住院确诊的脑静脉血栓形成(CVT)患者653例(中位年龄41岁,女性67%),并按年龄、性别和日历年匹配一般人群65300人。CVT患者其他部位静脉血栓栓塞、缺血性卒中、大出血和死亡风险升高,且风险随年龄和性别呈现异质性。
要点
- CVT患者其他部位静脉血栓栓塞风险升高,年轻患者(18—54岁)尤为突出。
- CVT患者缺血性卒中、大出血和死亡风险升高,老年患者(≥55岁)尤为突出。
- 年轻女性CVT患者10年其他部位静脉血栓栓塞风险为2.2%,匹配队列为0.4%(风险差1.8%,95%CI 0.0—3.6)。
核心结论
- CVT患者其他部位静脉血栓栓塞、缺血性卒中、大出血和死亡风险升高,心肌梗死风险未升高。
- 临床医生应认识到年龄和性别异质性在CVT预后中的重要性。
研究设计与样本
- 基于丹麦登记数据的全国性队列研究,纳入1996—2018年首次住院确诊的CVT患者653例(中位年龄41岁,女性67%)。
- 按年龄、性别和日历年匹配一般人群65300人作为对照。
主要发现
- 年轻女性CVT患者10年其他部位静脉血栓栓塞风险为2.2%,匹配队列为0.4%(风险差1.8%,95%CI 0.0—3.6)。
- 老年女性CVT患者10年缺血性卒中风险为12.8%,匹配队列为3.1%(风险差9.7%,95%CI 1.6—17.9)。
- 老年女性CVT患者10年大出血风险为11.1%,匹配队列为4.6%(风险差6.5%,95%CI -1.0—14.1)。
- 老年女性CVT患者10年全因死亡风险为43.1%,匹配队列为26.7%(风险差16.4%,95%CI 3.7—29.1)。
- 心肌梗死风险未升高。
关键数值与推荐
- 年轻女性CVT患者10年其他部位静脉血栓栓塞风险为2.2%,匹配队列为0.4%(风险差1.8%,95%CI 0.0—3.6)。
- 老年女性CVT患者10年缺血性卒中风险为12.8%,匹配队列为3.1%(风险差9.7%,95%CI 1.6—17.9)。
- 老年女性CVT患者10年大出血风险为11.1%,匹配队列为4.6%(风险差6.5%,95%CI -1.0—14.1)。
- 老年女性CVT患者10年全因死亡风险为43.1%,匹配队列为26.7%(风险差16.4%,95%CI 3.7—29.1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cerebral venous thrombosis (CVT) predominantly affects young to middle-aged women. Scarce data exist regarding the long-term prognosis. We examined the clinical course of patients with CVT overall and according to their age and sex. Using Danish registries, we identified all patients with a first-time primary inpatient diagnosis of CVT from 1996-2018 (N = 653; median age, 41 years; 67% women) and individuals from the general population matched for age, sex, and calendar year (N = 65 300). Patients with CVT were at an increased risk of venous thromboembolism (VTE) at other sites, ischemic stroke, major bleeding, and mortality. For both sexes, the increased risks of VTE at other sites were most prominent among younger patients (18-54 years), whereas the increased risks of ischemic stroke, major bleeding, and mortality were most prominent among older patients (≥55 years). Among young women, the 10-year risks of VTE at other sites for patients with CVT compared with members of the matched cohort were 2.2% vs 0.4% (risk difference, 1.8%; 95% confidence interval [CI], 0.0-3.6). Among older women, compared with members of the matched cohort, the 10-year risks were 12.8% vs 3.1% (risk difference, 9.7%; 95% CI, 1.6-17.9) for ischemic stroke, 11.1% vs 4.6% (risk difference, 6.5%; 95% CI, -1.0 to 14.1) for major bleeding, and 43.1% vs 26.7% (risk difference, 16.4%; 95% CI, 3.7-29.1) for all-cause mortality. The risk of myocardial infarction was not elevated. Clinicians should be aware of the importance of age and sex heterogeneity in the prognosis of CVT.
引用
- Skajaa N, Vandenbroucke JP, Simonsen CZ, et al. Thromboembolic events, bleeding, and mortality in patients with cerebral venous thrombosis: a nationwide cohort study. Blood Adv. 2023. PMID: 36112481. doi:10.1182/bloodadvances.2022008622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。